Etoposide (VP-16) plus G-CSF mobilizes different dendritric cell subsets than does G-CSF alone

Bone Marrow Transplantation

Volumn 31, Issue 2, 2003, Pages 95-98

  Bolwell, B ^a,b   Sobecks, R ^a,b   Pohlman, B ^a,b   Andresen, S ^a,b   Theil, K ^a,b   Serafino, S ^a,b   Rybicki, L ^a,b   Kalaycio, M ^a,b  

^a Dept of Hematology/Medical Oncology ^*  (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Autologous bone marrow transplant; Dendritic cells; Progenitor cell mobilization

Indexed keywords

CD123 ANTIGEN; CD34 ANTIGEN; ETOPOSIDE; GLYCOPROTEIN P 15095; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; BONE MARROW CELL; BREAST CANCER; CELL COUNT; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DONOR; DOSE RESPONSE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKAPHERESIS; LYMPHOID CELL; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TUMOR IMMUNOLOGY;

ADULT; AGED; CELL COUNT; DENDRITIC CELLS; ETOPOSIDE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0037286464     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703791     Document Type: Review

References (10)

1. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets: isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994; 153: 4016-4028.
2. Liso A, Stockerl-Goldstein KE, Aufferman-Gretzinger S et al. Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2000; 6: 621-627.
3. Small EJ, Fratesi P, Deese DM et al. Immunotherapy of hormone-refractory prostate cancer with antigen loaded dendritic cells. J Clin Oncol 2000; 18: 3894-3903.
4. Morse MA, Nair S, Fernandez-Casal M et al. Preoperative mobilization of circulating dendritic cells by Flt 3 ligand administration to patients with metastatic colon cancer. J Clin Oncol 2000; 18: 3883-3893.
5. bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948-2956.
6. Willmann K, Olweus J. Application note: Peripheral blood dendritic cells revealed by flow cytometry. BDBiosciences, San Jose, CA 23-3580-01, September 2000, www.bdbiosciences.com.
7. Arpinati M, Green C, Heimfeld S et al. Granulocyte-colony stimulating factor mobilizes T-helper 2-inducing dendritic cells. Blood 2000; 95: 2484-2490.
8. Morse MA, Vredenburgh J, Lyerly HK. A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy. J Hematother Stem Cell Res 1999; 8: 577-584.
9. Lebsack ME, Maraskovsky E, Roux E et al. Increased circulating dendritic cells in healthy human volunteers following administration of Flt3 ligand alone or in combination with GM-CSF or G-CSF. Blood 1998; 92(Suppl 1): 5079.
10. Lonial S, Rosenthal H, Feinstein B et al. A randomized study of G-CSF vs the combination of G-CSF/GM-CSF on mobilization of dendritic cells in peripheral stem cell grafts. Blood 2000; 96(Suppl. 1): 518a.